Cancer Council Queensland, Brisbane, Queensland, Australia.
Dermatology Research Centre, The University of Queensland, School of Medicine, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
JAMA Dermatol. 2014 Aug;150(8):864-72. doi: 10.1001/jamadermatol.2014.124.
Merkel cell carcinoma (MCC) is an uncommon but highly invasive form of skin cancer. The mechanisms that cause MCC are yet to be fully determined.
To compare the incidence and survival rates of MCC in Queensland, Australia, known to be a high-risk area, with MCC incidence and survival elsewhere in the world. We also analyzed incidence trends and differences in survival by key demographic and clinical characteristics.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of population-based administrative data for MCC collected by the Queensland Cancer Registry and supplemented with detailed histopathologic data. Deidentified records were obtained of all Queensland residents diagnosed as having MCC during the period from 1993 to 2010. A subsample of histopathologic records were reviewed by a senior dermatopathologist to determine the potential for misclassification. A total of 879 eligible cases of MCC were included in the study.
Incidence rates were directly age standardized to the 2000 United States Standard Population. Trends were examined using Joinpoint software with results expressed in terms of the annual percentage change. The period method was used to calculate 5-year relative survival, and adjusted hazard ratios were obtained from multivariate Poisson models.
There were 340 cases of MCC diagnosed in Queensland between 2006 and 2010, corresponding to an incidence rate of 1.6 per 100,000 population. Men (2.5 per 100,000) had higher incidence than women (0.9 per 100,000), and rates peaked at 20.7 per 100,000 for persons 80 years or older. The overall incidence of MCC increased by an average of 2.6% per year from 1993 onwards. Relative survival was 41% after 5 years, with significantly better survival found for those younger than 70 years at diagnosis (56%-60%), those with tumors on the face or ears (51%), and those with stage I lesions (49%).
Incidence rates for MCC in Queensland are at least double those of any that have been previously published elsewhere in the world. It is likely that Queensland's combination of a predominantly white population, outdoor lifestyle, and exposure to sunlight has played a role in this unwanted result. Interventions are required to increase awareness of MCC among clinicians and the public.
默克尔细胞癌(MCC)是一种罕见但具有高度侵袭性的皮肤癌。导致 MCC 的机制尚未完全确定。
比较澳大利亚昆士兰州(已知为高危地区)与世界其他地区的 MCC 发病率和生存率。我们还分析了按关键人口统计学和临床特征划分的发病率趋势和生存率差异。
设计、地点和参与者:对 1993 年至 2010 年期间由昆士兰癌症登记处收集的基于人群的 MCC 行政数据进行的回顾性队列研究,并辅以详细的组织病理学数据。获取了所有在该期间被诊断为患有 MCC 的昆士兰居民的匿名记录。对一部分组织病理学记录进行了高级皮肤科病理学家的审查,以确定潜在的分类错误。共有 879 例符合条件的 MCC 病例纳入研究。
发病率直接按 2000 年美国标准人口进行年龄标准化。使用 Joinpoint 软件检查趋势,结果以每年百分比变化表示。使用时期法计算 5 年相对生存率,并从多变量泊松模型获得调整后的危险比。
2006 年至 2010 年期间,昆士兰州共诊断出 340 例 MCC,发病率为每 100000 人 1.6 例。男性(每 100000 人 2.5 例)的发病率高于女性(每 100000 人 0.9 例),发病率峰值为 80 岁及以上人群的 20.7 例。自 1993 年以来,MCC 的总体发病率平均每年增加 2.6%。5 年后的相对生存率为 41%,诊断时年龄小于 70 岁的患者(56%-60%)、肿瘤位于面部或耳部的患者(51%)和 I 期病变患者(49%)的生存率明显更好。
昆士兰州的 MCC 发病率至少是世界其他地区已发表的发病率的两倍。昆士兰州以白人为主的人口、户外活动的生活方式以及暴露于阳光的综合作用可能导致了这一不理想的结果。需要采取干预措施,提高临床医生和公众对 MCC 的认识。